Cargando…

Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study

BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiog...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Dipika Kalyan, Potdar, Priyanka Nandkumar, Prithyani, Saurabh Suresh, Rodrigues, Silvia Victor, Shetty, Gaurav Prabhakar, Talati, Meenakshi Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906909/
https://www.ncbi.nlm.nih.gov/pubmed/31849402
http://dx.doi.org/10.4103/jisp.jisp_562_18
_version_ 1783478447519039488
author Mitra, Dipika Kalyan
Potdar, Priyanka Nandkumar
Prithyani, Saurabh Suresh
Rodrigues, Silvia Victor
Shetty, Gaurav Prabhakar
Talati, Meenakshi Abhay
author_facet Mitra, Dipika Kalyan
Potdar, Priyanka Nandkumar
Prithyani, Saurabh Suresh
Rodrigues, Silvia Victor
Shetty, Gaurav Prabhakar
Talati, Meenakshi Abhay
author_sort Mitra, Dipika Kalyan
collection PubMed
description BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiographically and to compare the histologic difference between PRF and T-PRF by light microscopy and scanning electron microscopy (SEM). MATERIALS AND METHODS: The present study is a split mouth randomised controlled trial study in which 20 sites were selected and randomly assigned equally into 10 sites each in group A [Test group=T-PRF] and group B [Control group=PRF]. Clinical parameters were evaluated at baseline,3 months and 9 months. Radiographic parameters were evaluated at baseline and 9 months. Histologic differences between light microscopy and SEM for both PRF and T-PRF was studied after sequential processing. RESULTS: There was marked reduction in Probing Pocket depth and gain in Clinical Attachment Level in both the T-PRF and PRF groups from baseline to 9 months in intragroup comparisons. However, on intergroup comparisons, no statistical significance was seen. Radiographically, mean defect depths for both the groups showed statistically significant reduction from baseline values to 9 months on intragroup comparisons but not on intergroup comparisons. In-vitro evaluation, on both light and scanning electron microscopy, T-PRF showed denser fibril meshwork as compared to PRF. CONCLUSION: The clinical parameters and radiographic outcomes showed marked improvement at 9 months with both PRF and T-PRF in the treatment of infrabony defects from baseline values in intragroup comparison. However, statistically efficacy of T-PRF was not seen to be superior to that of PRF both clinically and radiographically. Histologic evaluation showed T-PRF had denser fibrils as compared to PRF in both light and scanning electron microscopy.
format Online
Article
Text
id pubmed-6906909
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69069092019-12-17 Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study Mitra, Dipika Kalyan Potdar, Priyanka Nandkumar Prithyani, Saurabh Suresh Rodrigues, Silvia Victor Shetty, Gaurav Prabhakar Talati, Meenakshi Abhay J Indian Soc Periodontol Original Article BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiographically and to compare the histologic difference between PRF and T-PRF by light microscopy and scanning electron microscopy (SEM). MATERIALS AND METHODS: The present study is a split mouth randomised controlled trial study in which 20 sites were selected and randomly assigned equally into 10 sites each in group A [Test group=T-PRF] and group B [Control group=PRF]. Clinical parameters were evaluated at baseline,3 months and 9 months. Radiographic parameters were evaluated at baseline and 9 months. Histologic differences between light microscopy and SEM for both PRF and T-PRF was studied after sequential processing. RESULTS: There was marked reduction in Probing Pocket depth and gain in Clinical Attachment Level in both the T-PRF and PRF groups from baseline to 9 months in intragroup comparisons. However, on intergroup comparisons, no statistical significance was seen. Radiographically, mean defect depths for both the groups showed statistically significant reduction from baseline values to 9 months on intragroup comparisons but not on intergroup comparisons. In-vitro evaluation, on both light and scanning electron microscopy, T-PRF showed denser fibril meshwork as compared to PRF. CONCLUSION: The clinical parameters and radiographic outcomes showed marked improvement at 9 months with both PRF and T-PRF in the treatment of infrabony defects from baseline values in intragroup comparison. However, statistically efficacy of T-PRF was not seen to be superior to that of PRF both clinically and radiographically. Histologic evaluation showed T-PRF had denser fibrils as compared to PRF in both light and scanning electron microscopy. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6906909/ /pubmed/31849402 http://dx.doi.org/10.4103/jisp.jisp_562_18 Text en Copyright: © 2019 Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mitra, Dipika Kalyan
Potdar, Priyanka Nandkumar
Prithyani, Saurabh Suresh
Rodrigues, Silvia Victor
Shetty, Gaurav Prabhakar
Talati, Meenakshi Abhay
Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title_full Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title_fullStr Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title_full_unstemmed Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title_short Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
title_sort comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: an in vitro and in vivo study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906909/
https://www.ncbi.nlm.nih.gov/pubmed/31849402
http://dx.doi.org/10.4103/jisp.jisp_562_18
work_keys_str_mv AT mitradipikakalyan comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy
AT potdarpriyankanandkumar comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy
AT prithyanisaurabhsuresh comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy
AT rodriguessilviavictor comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy
AT shettygauravprabhakar comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy
AT talatimeenakshiabhay comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy